Source: BIOPORTFOLIO

The Electrospinning Company: World's First Synthetic Corneal Epithelial Transplant Approved for Clinical Trials

The first clinical trials introducing electrospinning technology to address the loss of vision due to scarring of the cornea have been approved to take place in the LVPrasad eye clinic in India. Membranes used in these initial trials will be produced by th...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Ann Kramer's photo - CEO of Electrospinning

CEO

Ann Kramer

CEO Approval Rating

70/100

Read more